FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 1 through 21 of 21

- SIC # 2840

Ticker Exchange Company Financial Reports SIC #
AYTU Nasdaq Aytu BioPharma, Inc. 2840
BCPC Nasdaq Balchem Corporation 2840
BORAY Over the counter Bora Pharmaceuticals Co., Ltd. 2840
CLPBY Over the counter Coloplast A/S 2840
COTY New York Coty Inc. 2840
DVHGD Over the counter Devonian Health Group Inc. 2840
EPC New York Edgewell Personal Care Company 2840
FBIO Nasdaq Fortress Biotech, Inc. 2840
FTLF Nasdaq FitLife Brands, Inc. 2840
KVUE New York Kenvue Inc. 2840
LRLCY Over the counter LOr?al S.A. 2840
MTEX Nasdaq Mannatech, Incorporated 2840
NAGE Nasdaq Niagen Bioscience, Inc. 2840
OGN New York Organon & Co. 2840
PBH New York Prestige Consumer Healthcare Inc. 2840
PHG New York Koninklijke Philips N.V. 2840
RICFY Over the counter Recordati Industria Chimica e Farmaceuti 2840
RYM Nasdaq RYTHM, Inc. 2840
SKIN Nasdaq The Beauty Health Company 2840
SMTI Nasdaq Sanara MedTech Inc. 2840
ZIVO Over the counter ZIVO Bioscience, Inc. 2840
Results 0 through 21 of 21